|
2023
|
Invention
|
Crystalline form of aspacytarabine intermediate. The present invention relates to crystalline pol... |
|
|
Invention
|
Compositions comprising aspacytarabine and additional compounds, and use thereof. The present inv... |
|
|
Invention
|
Crystalline forms of aspacytarabine. SS)-2-amino-4-((1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymet... |
|
2022
|
Invention
|
Cytarabine-amino acid based prodrug for the treatment of cancer. The present invention relates to... |
|
2021
|
Invention
|
Crystalline form of aspacytarabine.
The present invention relates to a novel crystalline polymor... |
|
|
Invention
|
Crystalline form of aspacytarabine. The present invention relates to a novel crystalline polymorp... |
|
|
Invention
|
Salts of conjugates for cancer therapy. The present invention relates to pharmaceutically accepta... |
|
|
Invention
|
Cytarabine conjugates for cancer therapy. The present invention relates to conjugates comprising ... |
|
|
Invention
|
Methods and regimens for the treatment of hematological cancer.
The invention provides methods a... |
|
|
Invention
|
Methods and regimens for the treatment of hematological cancer. The invention provides methods an... |
|
|
Invention
|
Aspacytarabine pharmaceutical compositions and uses thereof.
The present invention relates to a ... |
|
|
Invention
|
Aspacytarabine pharmaceutical compositions and uses thereof. The present invention relates to a c... |
|
2020
|
Invention
|
Combination cancer therapy.
The present invention relates to combination therapies of a cytarabi... |
|
2018
|
Invention
|
Combination cancer therapy with cytarabine-based compounds. The present invention relates to comb... |
|
2016
|
Invention
|
Salts of conjugates for cancer therapy. Provided relates to pharmaceutically acceptable salts of ... |
|
|
Invention
|
Cytarabine conjugates for cancer therapy. Provided relates to conjugates including cytarabine and... |
|
2011
|
Invention
|
Conjugates for cancer therapy and diagnosis. The present invention relates to conjugates of a dru... |
|
2009
|
Invention
|
Peptide conjugated anti-cancer prodrugs. The present invention relates to prodrug molecules compr... |
|
2006
|
Invention
|
Peptide conjugated anti-cancer prodrugs. The present invention relates to pharmaceutical composit... |
|
2005
|
Invention
|
Activated labeling reagents and methods for preparing and using the same. The present invention r... |
